Precision Stroke Care, Powered by AI
Who we are
NeuroPred, founded in April 2024, is at the forefront of precision health, revolutionizing stroke care with AI-driven personalized prognosis. Emerging from pioneering research at the University of Iowa, we’re developing a state-of-the-art system that leverages advanced outcome prediction from neurological damage—transforming complex MRI analysis from hours of expert labor into minutes of automated insight. Our transformative technology delivers detailed, centralized Automated Reports that empower clinicians—from radiologists and neurologists to family physicians and rehab specialists—with actionable, patient-specific data integrated into medical records. By bridging care gaps between urban and rural settings, NeuroPred ensures every patient benefits from expert-level neurological insights, driving truly personalized care and redefining the future of stroke recovery.
Meet the Founders
Michal Brzus, Ph.D.
Michal is a visionary leader and the creator of NeuroPred’s groundbreaking technology, which is transforming stroke prognosis through AI and medical image processing. His expertise in developing open-source solutions, now integrated into clinical practice by FDA-approved companies, has established him as a pioneer in bridging technology and healthcare. Driven by a personal commitment to improving stroke outcomes, Michal combines technical brilliance with strategic leadership, guiding NeuroPred through competitive programs, securing vital funding, and shaping its intellectual property vision. His ability to inspire and innovate positions him as the driving force behind NeuroPred’s growth and its promise to revolutionize patient care.
Hans Johnson, Ph.D.
Hans brings a distinguished career in medical imaging and software engineering to his role as NeuroPred’s Chief Technology Officer. A pioneer in the field, he was instrumental in developing ITK, the foundational toolkit that underpins the entire medical imaging industry, and contributed to the early stages of MONAI, a leading framework for medical AI. His extensive experience as a professor at the University of Iowa and a proven leader in multi-site research projects ensures NeuroPred’s technology is robust, scalable, and compliant with regulatory standards, including FDA processes. Hans’s exceptional technical leadership and commitment to excellence make him a cornerstone of NeuroPred’s mission to advance stroke prognosis with precision and integrity.
Aaron Boes, M.D, Ph.D.
Aaron Boes is an internationally respected clinician and researcher, serving as Chair of Pediatric Neurology at the University of Iowa and a pioneer in brain lesion-based outcome prediction. With extensive NIH-funded research and direct experience caring for stroke patients, he offers a unique blend of clinical insight and scientific rigor to NeuroPred. His groundbreaking contributions to lesion network mapping and cognitive outcome analysis shape the company’s AI tools, ensuring they deliver actionable, patient-focused results. Aaron’s dual expertise as a physician and investigator strengthens NeuroPred’s ability to bridge advanced neuroscience with meaningful healthcare solutions.
Joel Bruss, B.A.
Joel Bruss is a seasoned expert in neuroscience and imaging data management, bringing over two decades of experience to his critical role at NeuroPred. His work with one of the world’s most extensive lesion registries and collaborations with leading neuroscientists have honed his ability to uncover intricate connections between brain function and behavior. Joel’s proficiency in advanced imaging and data stewardship underpins NeuroPred’s AI models with robust, meticulously curated datasets. His dedication to scientific precision and innovation empowers the company to deliver transformative, data-driven tools for stroke prognosis.